About this trial
The purpose of this study is to obtain unused resected tumor tissue sample and associated clinical data from patients enrolled in this study to research ex vivo treatment response and integrity of tumor microenvironment using omics analysis and imaging while maintaining cell stability in a live environment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Ability to understand and sign informed consent
Planning to undergo a surgical procedure to remove cancer
Disqualifiers
Does not meet Inclusion criteria
No tissue for research available at time of surgery
Trial population
Male and female patients planning to undergo surgery for removal of cancer at Mayo Clinic in Florida.
Trial design
Cohort
Prospective
Treatments tested in this trial
No intervention
Other interventionLab-based correlative study; no intervention
Treatment groups
Trial outcomes
Primary outcomes
Tissue response to treatment
Tumor sample fragments will be treated with various combination of chemotherapy and immunotherapy drugs that are commonly used to treat patients clinically (panel of drugs will be selected based on cancer type). response to the treatment will be assessed at multiple timepoints during a 72-hour period.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.